Skip to product information
1 of 1

Shulph Ink

Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification, An Issue of Cardiac Electrophysiology Clinics

Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification, An Issue of Cardiac Electrophysiology Clinics

Regular price £56.53 GBP
Regular price £61.99 GBP Sale price £56.53 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.
  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification, An Issue of Cardiac Electrophysiology Clinics

Cardiac Electrophysiology Clinics, Guest Edited by Drs. Mohammad Shenasa, Prashanthan Sanders, and Stanley Nattel, is dedicated to Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification. This issue covers topics such as epidemiology, hypertension, pulmonary disease, heart failure, coronary artery disease, ECG and echo abnormalities, diabetes, endocrine disorders, obesity, metabolic syndrome, renal disease, sleep apnea, channelopathies, inflammation, myocardial fibrosis, role of biomarkers, left ventricular hypertrophy, atrial fibrillation in valvular heart disease, adult congenital heart disease, exercise and athletic activity, post-op atrial fibrillation, autonomic dysfunction, neurohormonal disorders, social risk factors, atrial fibrillation and stroke, screening for atrial fibrillation risk factors, primary care and internists perspective, and lifestyle as a risk factor for atrial fibrillation.

Format: Hardback
Length: 240 pages
Publication date: 19 February 2021
Publisher: Elsevier - Health Sciences Division

The issue of Cardiac Electrophysiology Clinics,Guest Edited by Drs. Mohammad Shenasa,Prashanthan Sanders,and Stanley Nattel,is dedicated to Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification. This is one of four issues selected each year by the series Consulting Editors,Ranjan K. Thakur and Andrea Natale. Topics include,but are not limited to,Epidemiology of Atrial Fibrillation; Hypertension,Prehypertension,Hypertensive Heart Disease and Atrial Fibrillation; Pulmonary Disease,Pulmonary Hypertension and Atrial Fibrillation; Heart Failure with Preserved (HFpEF) and Reduced (HFrEF) LV Systolic Function,Diastolic Dysfunction; Coronary Artery Disease; ECG and Echo Abnormalities in Patients with Atrial Fibrillation Risk Factors; Diabetes and Endocrine Disorders; Obesity and Metabolic Syndrome in Atrial Fibrillation; Renal Disease; Sleep Apnea and Atrial Fibrillation; Channelopathies in Atrial Fibrillation; Implications of Inflammation and Myocardial Fibrosis in Atrial Fibrillation; Role of Biomarkers in Atrial Fibrillation; Left Ventricular Hypertrophy and Other Cardiomyopathies in Atrial Fibrillation; Atrial Fibrillation in Valvular Heart Disease; Atrial Fibrillation in Adult Congenital Heart Disease; Exercise and Athletic Activity in Atrial Fibrillation; Post-op Atrial Fibrillation; Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation; Social Risk Factors; Atrial Fibrillation and Stroke; Screening for Atrial Fibrillation Risk Factors; Primary Care and Internists Perspective on Atrial Fibrillation Risk Factors; and Lifestyle as a Risk Factor for Atrial Fibrillation.

The issue of Cardiac Electrophysiology Clinics,Guest Edited by Drs. Mohammad Shenasa,Prashanthan Sanders,and Stanley Nattel,is dedicated to Risk Factors in Atrial Fibrillation: Appraisal of AF Risk Stratification. This is one of four issues selected each year by the series Consulting Editors,Ranjan K. Thakur and Andrea Natale. Topics include,but are not limited to,Epidemiology of Atrial Fibrillation; Hypertension,Prehypertension,Hypertensive Heart Disease and Atrial Fibrillation; Pulmonary Disease,Pulmonary Hypertension and Atrial Fibrillation; Heart Failure with Preserved (HFpEF) and Reduced (HFrEF) LV Systolic Function,Diastolic Dysfunction; Coronary Artery Disease; ECG and Echo Abnormalities in Patients with Atrial Fibrillation Risk Factors; Diabetes and Endocrine Disorders; Obesity and Metabolic Syndrome in Atrial Fibrillation; Renal Disease; Sleep Apnea and Atrial Fibrillation; Channelopathies in Atrial Fibrillation; Implications of Inflammation and Myocardial Fibrosis in Atrial Fibrillation; Role of Biomarkers in Atrial Fibrillation; Left Ventricular Hypertrophy and Other Cardiomyopathies in Atrial Fibrillation; Atrial Fibrillation in Valvular Heart Disease; Atrial Fibrillation in Adult Congenital Heart Disease; Exercise and Athletic Activity in Atrial Fibrillation; Post-op Atrial Fibrillation; Autonomic Dysfunction and Neurohormonal Disorders in Atrial Fibrillation; Social Risk Factors; Atrial Fibrillation and Stroke; Screening for Atrial Fibrillation Risk Factors; Primary Care and Internists Perspective on Atrial Fibrillation Risk Factors; and Lifestyle as a Risk Factor for Atrial Fibrillation.

Weight: 770g
Dimension: 185 x 262 x 23 (mm)
ISBN-13: 9780323827744

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Canada, France, Ireland, Germany, Spain, New Zealand and the United States of America.

  • Delivery times: within 5 - 20 business days when ordering to France, Germany, Ireland, Spain, Canada and the United States. Up to 30 business days for Australia and New Zealand.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for international orders.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details